CHAI has country offices in more than 25 countries across the developing world.
We work in cooperation with and at the service of partner governments.
When invited by these governments, CHAI works as trusted advisors to expand access to treatment, strengthen management capacity, and improve procurement and laboratory systems. We also work to expand the health care workforce, and particularly seek to extend care to underserved populations, such as children and people living in rural areas.
CHAI’s global program staff work seamlessly with our country offices to support each country’s programmatic priorities, and help ensure that the health systems, policy environment, and marketplace for drugs and diagnostics enable governments to provide the access to healthcare that their citizens require.
Currently, over 70 countries have access to reduced prices achieved by CHAI’s innovative negotiations with companies. Almost 4 million people – representing more than 70% of people being treated for HIV/AIDS in low- and middle-income countries – have benefited from these reduced-price medicines. Since 2006, we have achieved 50-90% reductions in the prices of key antiretroviral drug regimens, which have yielded more than $1 billion in cost savings and enabled significant scale-up of treatment programs.